Open AccessCryptococcemia in a COVID-19 Patient: A Case Report
Author(s) -
Loubna Darfaoui,
Mohamed Esbaai,
Ayoub Belhaj,
El Aissaoui Youness,
El Mostafa El Mezouari,
R. Moutaj
Publication year - 2022
Publication title -
saudi journal of medicine
Language(s) - English
Resource type - Journals
eISSN - 2518-3397
pISSN - 2518-3389
DOI - 10.36348/sjm.2022.v07i01.013
Subject(s) - cryptococcus neoformans , cryptococcosis , cryptococcus , yeast , cycloheximide , virology , human immunodeficiency virus (hiv) , medicine , microbiology and biotechnology , opportunistic infection , covid-19 , aids related opportunistic infections , opportunistic pathogen , fluconazole , antifungal , biology , immunology , sida , viral disease , pathology , cell culture , genetics , disease , infectious disease (medical specialty) , biochemistry , virulence , gene
Cryptococcosis is a frequent and severe opportunistic mycosis caused by encapsulated yeast of the genus Cryptococcus. It is common in immunocompromised patients, particularly those infected with the human immunodeficiency virus. We report in our work a case of cryptococcemia in a patient with covid-19 under anti-inflammatory treatment. The diagnosis was based on the presence of encapsulated yeasts with Indian ink and positive culture on Sabouraud medium without cycloheximide with identification of Cryptococcus neoformans as the causative agent. The patient's outcome was fatal.